bupivacaine has been researched along with 15-hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic acid in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Durieux, M; Erera, JS; Gear, AR; Honemann, CW; Lo, B; Polanowska-Grabowska, R | 1 |
| Durieux, ME; Gear, AR; Hollmann, MW; Hönemann, CW; Kohrs, R; Lo, B; Polanowska-Grabowska, RK | 1 |
| Durieux, ME; Hahnenkamp, K; Halene, T; Hoenemann, CW; Knapp, J; Mortier, E; Mper, DS; Nollet, J; Rathman, P; Van Aken, H | 1 |
3 other study(ies) available for bupivacaine and 15-hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic acid
| Article | Year |
|---|---|
Local anesthetic effects on TXA2 receptor mediated platelet aggregation using quenched flow aggregometry.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Amides; Anesthetics, Local; Blood Platelets; Bridged Bicyclo Compounds, Heterocyclic; Bupivacaine; Fatty Acids, Unsaturated; Humans; Hydrazines; In Vitro Techniques; Lidocaine; Platelet Aggregation; Receptors, Thromboxane; Ropivacaine; Signal Transduction; Thromboxane A2 | 1999 |
Local anesthetic actions on thromboxane-induced platelet aggregation.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Adenosine Diphosphate; Amides; Anesthetics, Local; Bupivacaine; Humans; Lidocaine; Platelet Aggregation; Ropivacaine; Thromboxane A2 | 2001 |
Bupivacaine inhibits thromboxane A2-induced vasoconstriction in rat thoracic aorta.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Algorithms; Anesthetics, Local; Animals; Aorta, Thoracic; Bupivacaine; Carbachol; Dose-Response Relationship, Drug; Endothelium, Vascular; In Vitro Techniques; Male; Muscarinic Agonists; Norepinephrine; Rats; Rats, Wistar; Thromboxane A2; Vasoconstrictor Agents | 2004 |